Centralized migration accelerates adaptation and drives parallel evolution, emphasizing the key influence of spatial organization on evolutionary dynamics across systems from pathogen transmission to ...
Medical technology company Abanza has received FDA 510(k) clearance for QuadLock, a fixation system for ACL reconstruction. The system can be used across several graft configurations that are ...
ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...
ABANZA’s QuadLock™ delivers market-leading fixation strength with over a 500% reduction in cyclic displacement compared to conventional fixation methods. QuadLock™ is designed to securely fixate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results